Helix Acquisition Corp, a Nasdaq-listed special purpose acquisition company and MoonLake Immunotherapeutics, a Swiss based clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases agreed on a business combination. At
Tags :Jonas Sigrist
Pestalozzi advises global institutional investors in connection with up to $ 44,000,000 equity linked investment in WISeKey International Holding listed at SIX Swiss Exchange and with ADS traded at Nasdaq. The investment is structured in two convertible
The Pestalozzi team included Sébastien Roy (Partner - Financial Services), Ludivine Boisard (Partner - Financial Services), Jonas Sigrist (Partner - Tax), Jean-Baptiste Lhôte (Associate - Financial Services), Frédéric Moioli (Associate -
The Pestalozzi team included Sébastien Roy (Partner - Financial Services - pictured), Thomas Rohner (Partner - Restructuring & Insolvency), Jonas Sigrist (Partner - Tax), Ludivine Boisard (Partner - Financial Services), Christian Roos (Partner - Employment &
The team included Beat Schwarz (Partner - Corporate / M&A - pictured), Ludivine Boisard (Partner - Financial Services), Jonas Sigrist (Partner - Tax), Martin L. Mueller (Partner - Employment), Noëlle Mathis (Senior Associate -
The team included Franz Schubiger (Partner - Corporate / M&A, Life Sciences - pictured), Christian Roos (Partner - Employment & Pensions, Regulatory), Beat Schwarz (Partner - Corporate / M&A), Jonas Sigrist (Partner - Tax)
